Royalty Pharma PLC (rprx 3.3 09/02/40)
13F holders, Q1 2025 (March 31)1holders
$0.74avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Royalty Pharma PLC (rprx 3.3 09/02/40) in their 13F filings. The largest holder was Pacer Advisors, Inc. ($29K).
- Company
- Royalty Pharma PLC (rprx 3.3 09/02/40)
- CUSIP
- 78081BAL7
- Latest filing quarter
- Q1 2025
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $29K |
| Exits | 0 | $0 |
Ownership 1 holders
| Pacer Advisors, Inc. | 0.00% | New | 39,000 | $29K |
"% of holder's portfolio" is ROYALTY PHARMA PLC (RPRX 3.3 09/02/40)'s weight in each manager's 13F, not the share of Royalty Pharma PLC (rprx 3.3 09/02/40) the manager owns.